The evolution of no-cost resistance at sub-MIC concentrations of streptomycin in Streptomyces coelicolor

ISME Journal

Volumn 11, Issue 5, 2017, Pages 1168-1178

  Westhoff, Sanne ^a   Van Leeuwe, Tim Marijn ^a   Qachach, Omar ^a   Zhang, Zheren ^a   Van Wezel, Gilles Philippus ^a,b   Rozen, Daniel Eric ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b NETHERLANDS INSTITUTE OF ECOLOGY NIOO KNAW   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBIOTICS; BACTERIUM; CLONE; CONCENTRATION (COMPOSITION); EVOLUTION; FITNESS; MUTATION; SOIL ECOSYSTEM; SOIL MICROORGANISM;

BACTERIA (MICROORGANISMS); STREPTOMYCES COELICOLOR;

ANTIINFECTIVE AGENT; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; DRUG EFFECTS; EVOLUTION; GENETICS; MICROBIOLOGY; MUTATION; STREPTOMYCES COELICOLOR;

ANTI-BACTERIAL AGENTS; BIOLOGICAL EVOLUTION; DRUG RESISTANCE, BACTERIAL; MUTATION; SOIL MICROBIOLOGY; STREPTOMYCES COELICOLOR; STREPTOMYCIN;

EID: 85009808573     PISSN: 17517362     EISSN: 17517370     Source Type: Journal    
DOI: 10.1038/ismej.2016.194     Document Type: Article

References (50)

1. Abrudan MI, Smakman F, Grimbergen AJ, Westhoff S, Miller EL, van Wezel GP et al. (2015). Socially mediated induction and suppression of antibiosis during bacterial coexistence. Proc Natl Acad Sci USA 112: 11054-11059.
2. Allen HK, Donato J, Wang HH, Cloud-Hansen KA, Davies J, Handelsman J. (2010). Call of the wild: antibiotic resistance genes in natural environments. Nat Rev Microbiol 8: 251-259.
3. Allen HK, Moe La, Rodbumrer J, Gaarder A, Handelsman J. (2009). Functional metagenomics reveals diverse beta-lactamases in a remote Alaskan soil. ISME J 3: 243-251.
4. Aminov RI. (2009). The role of antibiotics and antibiotic resistance in nature. Environ Microbiol 11: 2970-2988.
5. Andersson Di, Hughes D. (2011). Persistence of antibiotic resistance in bacterial populations. FEMS Microbiol Rev 35: 901-911.
6. Andersson Di, Hughes D. (2014). Microbiological effects of sublethal levels of antibiotics. Nat Rev Microbiol 12: 465-478.
7. Andersson Di, Levin BR. (1999). The biological cost of antibiotic resistance. Curr Opin Microbiol 2: 489-493.
8. Baquero F. (2001). Low-level antibacterial resistance: a gateway to clinical resistance. Drug Resist Updat 4: 93-105.
9. Baquero F, Alvarez-Ortega C, Martinez JL. (2009). Ecology and evolution of antibiotic resistance. Environ Microbiol Rep 1: 469-476.
10. Baquero F, Negri M, Morosini M-I, Blazquez J. (1998). Antibiotic-selective environments. Clin Infect Dis 27: 5-11.
11. Barka EA, Vatsa P, Sanchez L, Gaveau-vaillant N, Jacquard C, Klenk H-P et al. (2016). Taxonomy, physiology, and natural products of actinobacteria. Microbiol Mol Biol Rev 80: 1-43.
12. Chow L, Waldron L, Gillings MR. (2015). Potential impacts of aquatic pollutants: sub-clinical antibiotic concentrations induce genome changes and promote antibiotic resistance. Front Microbiol 6: 1-10.
13. D'Costa VM, King CE, Kalan L, Morar M, Sung WWL, Schwarz C et al. (2011). Antibiotic resistance is ancient. Nature 477: 457-461.
14. D'Costa VM, McGrann K, Hughes DW, Wright GD. (2006a). Sampling the antibiotic resistome. Science 311: 374-377.
15. D'Costa VM, McGrann KM, Hughes DW, Wright GD. (2006b). Sampling the antibiotic resistome. Science 311: 374-377.
16. Davies J, Davies D. (2010). Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74: 417-433.
17. Davies J, Spiegelman GB, Yim G. (2006). The world of subinhibitory antibiotic concentrations. Curr Opin Microbiol 9: 445-453.
18. Drlica K, Zhao X. (2007). Mutant selection window hypothesis updated. Clin Infect Dis 44: 681-688.
19. Drusano GL. (2004). Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'. Nat Rev Microbiol 2: 289-300.
20. Forsberg KJ, Reyes A, Wang B, Selleck EM, Sommer MOA, Dantas G. (2012). The shared antibiotic resistome of soil bacteria and human pathogens. Science 337: 1107-1111.
21. Gullberg E, Cao S, Berg OG, Ilbäck C, Sandegren L, Hughes D et al. (2011). Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog 7: e1002158.
22. Hopwood DA. (2007). Streptomyces in Nature and Medicine: The Antibiotic Makers. Oxford University Press: New York, NY, US.A.
23. Hosaka T, Ohnishi-Kameyama M,Muramatsu H,Murakami K, Tsurumi Y, Kodani S et al. (2009). Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12. Nat Biotechnol 27: 462-464.
24. Huang TW, Chen CW. (2006). A recA null mutation may be generated in Streptomyces coelicolor. J Bacteriol 188: 6771-6779.
25. Hughes D, Andersson Di. (2012). Selection of resistance at lethal and non-lethal antibiotic concentrations. Curr Opin Microbiol 15: 555-560.
26. Jorgensen KM, Wassermann T, Jensen PO, Hengzuang W, Molin S, Hoiby N et al. (2013). Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa. Antimicrob Agents Chemother 57: 4215-4221.
27. Kahlmeter G, Brown DFJ, Goldstein FW, MacGowan AP, Mouton JW, Osterlund A et al. (2003). European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J Antimicrob Chemother 52: 145-148.
28. Kurland CG. (1992). Translational accuracy and the fitness of bacteria. Annu Rev Genet 26: 29-50.
29. Laskaris P, Gaze WH, Wellington EMH. (2011). Environmental reservoirs of resistance genes in antibioticproducing bacteria and their possible impact on the evolution of antibiotic resistance. In: Keen PL, Montforts MHMM (eds). Antimicrobial Resistance in the Environment. Wiley: New York, NY, pp 73-92.
30. Lenski R, Rose M, Simpson S, Tadler S. (1991). Long-term experimental evolution in Escherichia coli. I. Adaptation and divergence during 2,000 generations. Am Nat 138: 1315-1341.
31. Melnyk AH, Wong A, Kassen R. (2014). The fitness costs of antibiotic resistance mutations. Evol Appl 8: 273-283.
32. Negri MC, Lipsitch M, Blázquez J, Levin BR, Baquero F. (2000). Concentration-dependent selection of small phenotypic differences in TEM beta-lactamasemediated antibiotic resistance. Antimicrob Agents Chemother 44: 2485-2491.
33. Nishimura K, Hosaka T, Tokuyama S, Okamoto S, Ochi K. (2007a). Mutations in rsmG, encoding a 16S rRNA methyltransferase, result in low-level streptomycin resistance and antibiotic overproduction in Streptomyces coelicolor A3(2). J Bacteriol 189: 3876-3883.
34. Nishimura K, Johansen SK, Inaoka T, Hosaka T, Tokuyama S, Tahara Y et al. (2007b). Identification of the RsmG methyltransferase target as 16S rRNA nucleotide G527 and characterization of Bacillus subtilis rsmG mutants. J Bacteriol 189: 6068-6073.
35. van Overbeek LS, Wellington EMH, Egan S, Smalla K, Heuer H, Collard JM et al. (2002). Prevalence of streptomycin-resistance genes in bacterial populations in European habitats. (Special issue: The contribution of mobile genetic elements in bacterial adaptability and diversity.). FEMS Microbiol Ecol 42: 277-288
36. Raaijmakers JM, Mazzola M. (2012). Diversity and natural functions of antibiotics produced by beneficial and plant pathogenic bacteria. Annu Rev Phytopathol 50: 403-424.
37. Ruusala T, Andersson D, Ehrenberg M, Kurland CG. (1984). Hyper-accurate ribosomes inhibit growth. EMBO J 3: 2575-2580.
38. Sandegren L, Andersson Di. (2009). Bacterial gene amplification: implications for the evolution of antibiotic resistance. Nat Rev Microbiol 7: 578-588.
39. Schatz A, Bugie E, Waksman SA. (1944). Streptomycin, a substance exhibiting antibiotic activity against Grampositive and Gram-negative bacteria. Proc Soc Exp Biol Med 55: 66-69.
40. Tanaka Y, Komatsu M, Okamoto S, Tokuyama S, Kaji A, Ikeda H et al. (2009). Antibiotic overproduction by rpsL and rsmG mutants of various actinomycetes. Appl Environ Microbiol 75: 4919-4922.
41. Thiele-Bruhn S. (2003). Pharmaceutical antibiotic compounds in soils-a review. J Plant Nutr Soil Sci 166: 145-167.
42. Tolba S, Egan S, Kallifidas D, Wellington EMH. (2002). Distribution of streptomycin resistance and biosynthesis genes in streptomycetes recovered from different soil sites. FEMS Microbiol Ecol 42: 269-276.
43. Travisano M, Lenski RE. (1996). Long-term experimental evolution in Escherichia coli. IV. Targets of selection and the specificity of adaptation. Genetics 143: 15-26.
44. van Wezel GP, McDowall KJ. (2011). The regulation of the secondary metabolism of Streptomyces: new links and experimental advances. Nat Prod Rep 28: 1311.
45. Wu C, Du C, Gubbens J, Choi YH, van Wezel GP. (2015). Metabolomics-driven discovery of a prenylated isatin antibiotic produced by streptomyces species MBT28. J Nat Prod 78: 2355-2363.
46. Yeo KJ, Kim EH, Hwang E, Han Y-H, Eo Y, Kim HJ et al. (2013). pH-dependent structural change of the extracellular sensor domain of the DraK histidine kinase from Streptomyces coelicolor. Biochem Biophys Res Commun 431: 554-559.
47. Yim G, Wang HH, Davies J. (2006). The truth about antibiotics. Int J Med Microbiol 296: 163-170.
48. Yim G, Wang HH, Davies J. (2007). Antibiotics as signalling molecules. Philos Trans R Soc Lond Ser B 362: 1195-1200.
49. Yu Z, Zhu H, Dang F, Zhang W, Qin Z, Yang S et al. (2012). Differential regulation of antibiotic biosynthesis by DraR-K, a novel two-component system in Streptomyces coelicolor. Mol Microbiol 85: 535-556.
50. Zhu H, Swierstra J, Wu C, Girard G, Choi YH, van Wamel W et al. (2014). Eliciting antibiotics active against the ESKAPE pathogens in a collection of actinomycetes isolated from mountain soils. Microbiology 160: 1714-1725.